National Tuberous Sclerosis Day - May 15, 2027

National Tuberous Sclerosis Day is observed on May 15 to shine a light on a rare and frequently misunderstood genetic condition that affects people of all ages and backgrounds around the world. Tuberous Sclerosis Complex, also known as Bourneville-Pringle disease, causes benign tumors to grow in the brain and other vital organs, producing a wide range of symptoms that vary considerably from person to person and are often dismissed or misattributed because the condition is so rarely encountered in clinical practice.

National Tuberous Sclerosis Day History

Tuberous sclerosis has a documented history of roughly 160 years, emerging gradually from early pathological observations into the defined clinical entity it is recognized as today. One of the earliest public records of the condition came through a color plate illustration by P.F.O. Rayer depicting a patient with facial angiofibroma, the benign tumors that are among the condition's most visible markers. German pathologist Friedrich Daniel von Recklinghausen later contributed a report describing the death of a newborn attributed to cardiac myomas, benign heart tumors, alongside cerebral sclerosis, adding further clinical texture to what was still an incompletely understood phenomenon. The picture remained incomplete until 1880, when French neurologist D.M. Bourneville formally diagnosed a patient presenting with mental subnormality, hemiplegia, and seizure attacks, identifying the constellation of symptoms as a distinct disease and giving it the foundational clinical definition that still informs understanding today.

National Tuberous Sclerosis Day draws attention to the significant scientific progress that followed those early observations. As the 20th century opened, researchers began pairing clinical observation with more advanced diagnostic tools, producing a clearer and more comprehensive picture of how T.S.C. affects different organ systems. Dermal, renal, cardiac, and cerebral lesions consistent with facial angiofibromas and epilepsy were identified as characteristic features, giving clinicians a more reliable framework for diagnosis. Each new finding added resolution to what had previously been a blurry clinical portrait, helping to distinguish T.S.C. from other conditions with overlapping presentations and laying the groundwork for more targeted research into its causes and treatment.

The most transformative advances came with the identification of the specific gene mutations responsible for T.S.C., which opened entirely new lines of inquiry into how brain lesions form in patients, whether through hereditary transmission, pathophysiological processes, or neuropathological mechanisms. Diagnostic criteria have become considerably more precise, allowing clinicians to assess disease severity on an individual basis rather than applying a one-size-fits-all classification. Treatment has evolved in parallel, with a wide range of medical options now available that have largely replaced the earlier reliance on tumor surgery. The condition remains incurable, but its manageability has improved substantially, and ongoing genetic and pharmacological research continues to push toward better outcomes for patients across all ages.

Why National Tuberous Sclerosis Day Matters

Strength Comes From Community

Families navigating T.S.C. benefit enormously from connection with others who understand firsthand what the condition involves, from the practical challenges of managing symptoms to the emotional weight of an uncertain prognosis. Shared information, access to medical expertise, and the simple reassurance of not being alone are things that a strong community provides in ways that clinical settings alone cannot.

Being Seen Changes Everything

For people living with a condition that most of the world has never heard of, having a dedicated observance that draws public attention is not a symbolic gesture but a genuinely meaningful form of recognition. Support groups connected to this occasion provide counseling and community to both patients and their families, and the broader the observance grows, the more accessible those groups become to people who previously had nowhere to turn.

Science Needs the Fuel

Research into rare diseases moves slowly without consistent financial support, and the events, campaigns, and fundraising drives organized around this observance provide the resources that allow scientists and medical professionals to keep advancing their understanding of T.S.C. The proceeds fund not only laboratory research but also the development of programs and informational resources that help clinicians manage the condition more effectively.

How to Observe National Tuberous Sclerosis Day

Raise the Digital Flag

Download the T.S.C. Global Awareness Day coloring flyers available on the Tuberous Sclerosis International website, take a photo with your flyer, and post it to social media using the hashtags #TSCGlobalDay and #United4TSC to add your voice to the global conversation happening around this observance. Social media has proven to be one of the most effective tools for rare disease advocacy, capable of reaching people who would otherwise never encounter the issue.

Find Your Local Network

T.S.C. organizations in communities across the country hold local events, parades, symposiums, and fundraisers on May 15 each year, and reaching out to the one nearest you is one of the most direct ways to contribute something meaningful. These events bring together patients, families, researchers, and advocates in spaces that create both practical connections and genuine human solidarity.

Stand With the Global Movement

Supporting this observance alongside T.S.C. Global Awareness Day amplifies a message that needs as many voices as possible, contributing to a coordinated international push for visibility, research funding, and the dismantling of stigma that still surrounds the condition in many communities. Even a small individual action, sharing information, attending an event, or simply telling someone what T.S.C. is, adds to a collective effort that has real consequences for real patients.

Facts About Tuberous Sclerosis

Affects Every Organ Differently

T.S.C. can cause benign tumors to develop in the brain, kidneys, heart, lungs, and skin, with the combination and severity of organ involvement varying significantly between individuals even within the same family.

Gene Mutations Come in Two Forms

Tuberous sclerosis is caused by mutations in either the TSC1 or TSC2 gene, with TSC2 mutations generally associated with more severe clinical presentations than those involving TSC1.

It Affects About One in Six Thousand People

T.S.C. occurs in roughly one in every six thousand live births worldwide, making it rare enough that many clinicians go their entire careers without encountering a case.

Seizures Are the Most Common Symptom

Epilepsy affects approximately 80 to 90 percent of people with T.S.C., often beginning in infancy, and managing seizure activity is frequently the central focus of treatment throughout a patient's life.

Named After Two Physicians

The alternative name Bourneville-Pringle disease combines the names of French neurologist D.M. Bourneville, who first formally defined the condition in 1880, and British dermatologist John James Pringle, who later described its distinctive skin manifestations.

National Tuberous Sclerosis Day Dates